Related references
Note: Only part of the references are listed.Glucose transporter 4: Insulin response mastermind, glycolysis catalyst and treatment direction for cancer progression
Yu-Chan Chang et al.
CANCER LETTERS (2023)
Ginsenoside Rg3 inhibits angiogenesis in gastric precancerous lesions through downregulation of Glut1 and Glut4
Zhongzhen Zeng et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Helichrysetin inhibits gastric cancer growth by targeting c-Myc/PDHK1 axis-mediated energy metabolism reprogramming
Ping Wang et al.
ACTA PHARMACOLOGICA SINICA (2022)
Key Molecules of Fatty Acid Metabolism in Gastric Cancer
Chunlei Li et al.
BIOMOLECULES (2022)
Isoliquiritigenin Inhibits Gastric Cancer Stemness, Modulates Tumor Microenvironment, and Suppresses Tumor Growth through Glucose-Regulated Protein 78 Downregulation
Chien-Hsing Lee et al.
BIOMEDICINES (2022)
Salidroside Induces Apoptosis in Human Gastric Cancer Cells via the Downregulation of ENO1/PKM2/GLUT1 Expression
Ziying Dai et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2021)
Hypoxia-induced FOXO4/LDHA axis modulates gastric cancer cell glycolysis and progression
Xiao-Hong Wang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4
Ting Guo et al.
CANCER COMMUNICATIONS (2021)
Galangin Inhibits Gastric Cancer Growth Through Enhancing STAT3 Mediated ROS Production
Xiaohui Liang et al.
FRONTIERS IN PHARMACOLOGY (2021)
The Role of PCC-lα in Digestive System Malignant Tumours
Qiushuang Zhang et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2020)
The curcumin analogue WZ35 affects glycolysis inhibition of gastric cancer cells through ROS-YAP-JNK pathway
Tongke Chen et al.
FOOD AND CHEMICAL TOXICOLOGY (2020)
An essential herbal medicine-licorice: A review of phytochemicals and its effects in combination preparations
Maoyuan Jiang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
Metabolic reprogramming and cancer progression
Brandon Faubert et al.
SCIENCE (2020)
MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer
Honglei Wu et al.
CELL DEATH & DISEASE (2020)
Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism
Jiyoung Lee et al.
NATURE (2019)
Isoliquiritigenin suppresses the proliferation and induced apoptosis via miR-32/LATS2/Wnt in nasopharyngeal carcinoma
Ting-Ting Wang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition
Alberto Cruz-Bermudez et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
KLF8 is associated with poor prognosis and regulates glycolysis by targeting GLUT4 in gastric cancer
Anwei Mao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells
Lihua Chen et al.
CELLULAR ONCOLOGY (2019)
Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming
Jinmei Jin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Isoliquiritigenin, an Orally Available Natural FLT3 Inhibitor from Licorice, Exhibits Selective Anti-Acute Myeloid Leukemia Efficacy In Vitro and In Vivo
Zhi-Xing Cao et al.
MOLECULAR PHARMACOLOGY (2019)
Crosstalk of mTOR/PKM2 and STAT3/c-Myc signaling pathways regulate the energy metabolism and acidic microenvironment of gastric cancer
Sumeng Gao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
The role of surgical resection before palliative chemotherapy in advanced gastric cancer
Yong Won Choi et al.
SCIENTIFIC REPORTS (2019)
BCL-2 proteins and apoptosis: Recent insights and unknowns
Frank Edlich
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling
Ming Luo et al.
CELL METABOLISM (2018)
Cardiotoxic effects of chemotherapy: A review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system
Hani M. Babiker et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1 alpha axis to inhibit gastric tumorigenesis
Weilin Li et al.
ONCOGENE (2018)
Protective effect of the BET protein inhibitor JQ1 in cisplatin-induced nephrotoxicity
Liping Sun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
Molecular intricacies of aerobic glycolysis in cancer: current insights into the classic metabolic phenotype
Shanmugasundaram Ganapathy-Kanniappan
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2018)
Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival
Hans Anton Schloesser et al.
GASTRIC CANCER (2017)
Gimatecan exerts potent antitumor activity against gastric cancer in vitro and in vivo via AKT and MAPK signaling pathways
Zuhua Chen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Targeted therapies for gastric cancer: failures and hopes from clinical trials
Maria Apicella et al.
ONCOTARGET (2017)
Hacking Cancer Metabolism
Anne Granger et al.
Cell Metabolism (2016)
A new mechanism of trastuzumab resistance in gastric cancer: MACC1 promotes the Warburg effect via activation of the PI3K/AKT signaling pathway
Jing Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial
Kazumasa Fujitani et al.
LANCET ONCOLOGY (2016)
MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1α regulation
L. Liu et al.
ONCOGENESIS (2016)
Mitochondrial apoptosis: killing cancer using the enemy within
J. Lopez et al.
BRITISH JOURNAL OF CANCER (2015)
MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells
Patricia Sancho et al.
CELL METABOLISM (2015)
PGC-lα mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis
Valerie S. LeBleu et al.
NATURE CELL BIOLOGY (2014)
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Peter E. Czabotar et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
PGC1α Expression Defines a Subset of Human Melanoma Tumors with Increased Mitochondrial Capacity and Resistance to Oxidative Stress
Francisca Vazquez et al.
CANCER CELL (2013)
c-Myc and Cancer Metabolism
Donald M. Miller et al.
CLINICAL CANCER RESEARCH (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Differential effects of 5-fluorouracil on glucose transport and expressions of glucose transporter proteins in gastric cancer cells
Hye-Jin Won et al.
ANTI-CANCER DRUGS (2010)
Mammalian Target of Rapamycin Pathway Promotes Tumor-Induced Angiogenesis in Adenoid Cystic Carcinoma: Its Suppression by Isoliquiritigenin through Dual Activation of c-Jun NH2-Terminal Kinase and Inhibition of Extracellular Signal-Regulated Kinase
Zhi-Jun Sun et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Cancer as a metabolic disease
Thomas N. Seyfried et al.
NUTRITION & METABOLISM (2010)
Isoliquiritigenin, a Flavonoid from Licorice, plays a Dual Role in regulating Gastrointestinal Motility in vitro and in vivo
Gang Chen et al.
PHYTOTHERAPY RESEARCH (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Hypoxia-inducible factor I and dysregulated c-myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1
Jung-Whan Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation
John D. Gordan et al.
CANCER CELL (2007)
Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators
Julie St-Pierre et al.
CELL (2006)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis
F Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells
J Ma et al.
PLANTA MEDICA (2001)
Accelerated publication -: Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc
RC Osthus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
